BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 13746610)

  • 1. Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
    SARTORELLI AC; BOOTH BA
    Biochem Pharmacol; 1960 Nov; 5():245-50. PubMed ID: 13746610
    [No Abstract]   [Full Text] [Related]  

  • 2. SOME FACTORS AFFECTING THE TUMOR-INHIBITORY PROPERTIES OF COMBINATIONS OF AZASERINE AND 6-CHLOROPURINE.
    SARTORELLI AC; BOOTH BA
    Biochem Pharmacol; 1963 Aug; 12():847-53. PubMed ID: 14071542
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of the biosynthesis of purines de novo by 6-chloropurine and azaserine in sensitive and naturally resistant ascites cells.
    SARTORELLI AC; AKERS JR; BOOTH BA
    Biochem Pharmacol; 1960 Nov; 5():238-44. PubMed ID: 13746609
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of sarcoma 180 by combinations of DL-glyceraldehyde with 6-thioguanine or with azaserine and 6-chloro-purine.
    SARTORELLI AC; SCHOOLAR EJ; KRUSE PF
    Proc Soc Exp Biol Med; 1960 Jun; 104():266-8. PubMed ID: 14441826
    [No Abstract]   [Full Text] [Related]  

  • 5. Antineoplastic activity of combinations of 6-chloropurine and azaserine.
    SARTORELLI AC; BOOTH BA
    Cancer Res; 1960 Feb; 20():198-203. PubMed ID: 14441824
    [No Abstract]   [Full Text] [Related]  

  • 6. GROWTH INHIBITION OF A SPECTRUM OF TRANSPLANTED MOUSE TUMORS BY COMBINATIONS OF INHIBITORS OF NUCLEIC ACID BIOSYNTHESIS AND ALKYLATING AGENTS.
    BOOTH BA; SARTORELLI AC
    Cancer Res; 1963 Dec; 23():1762-8. PubMed ID: 14082870
    [No Abstract]   [Full Text] [Related]  

  • 7. SOME METABOLIC EFFECTS EXERTED BY AZASERINE AND PURINE ANALOGS IN VIVO.
    SARTORELLI AC; UPCHURCH HF; BIEBER AL; BOOTH BA
    Cancer Res; 1964 Aug; 24():1202-9. PubMed ID: 14216152
    [No Abstract]   [Full Text] [Related]  

  • 8. AZASERINE AND THIOPURINES. I. INHIBITION OF S-180 MOUSE TUMOR AND ANTIBODY SYNTHESIS.
    HANSEN HJ; VANDEVOORDE JP; BENNETT KJ; GILES WG; NADLER SB
    J Lab Clin Med; 1964 May; 63():801-18. PubMed ID: 14158063
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative studies on the in vivo action of 6-chloropurine, 6-chloropurine ribonucleoside, and 6-chloro-9-ethylpurine on sarcoma 180 ascites cells.
    SARTORELLI AC; BOOTH BA
    J Pharmacol Exp Ther; 1961 Oct; 134():123-8. PubMed ID: 14497281
    [No Abstract]   [Full Text] [Related]  

  • 10. Purine metabolism in bacteria. IV. L-azaserine as an inhibitor.
    GOLLUB EG; GOTS JS
    J Bacteriol; 1956 Dec; 72(6):858-64. PubMed ID: 13398378
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion of 6-chloropurine to its ribonucleotide by ascites tumor cells.
    Hampton A; Paterson AR
    Biochim Biophys Acta; 1966 Jan; 114(1):185-7. PubMed ID: 5936954
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of histidine and its metabolites on the biosynthesis of purines by Escherichia coli B. IV. Action on some cultures inhibited by azaserine].
    HEDEGAARD J; MASPERO SEGRE S; NGUYEN VAN THOAI ; ROCHE J
    C R Seances Soc Biol Fil; 1959; 153():767-71. PubMed ID: 14400512
    [No Abstract]   [Full Text] [Related]  

  • 13. [Influence of histidine and of its metabolites on the biosynthesis of purines by Escherichia coli B. V. Mode of action in cultures inhibited by azaserine].
    HEDEGAARD J; MASPERO-SEGRE S; NGUYEN VAN THOAI ; ROCHE J
    C R Seances Soc Biol Fil; 1959; 153():767-71. PubMed ID: 13848416
    [No Abstract]   [Full Text] [Related]  

  • 14. THE UPTAKE OF FUANINE, URACIL, LYSINE AND GLYCINE BY ASCITES CELLS PRETREATED WITH AZASERINE AND 6-THIOGUANINE.
    ADAMS DH
    Biochem J; 1963 Nov; 89(2):240-8. PubMed ID: 14084607
    [No Abstract]   [Full Text] [Related]  

  • 15. BIOCHEMICAL EFFECTS OF DUAZOMYCIN A IN THE MOUSE PLASMA CELL NEOPLASM 70429.
    ANDERSON EP; BROCKMAN RW
    Biochem Pharmacol; 1963 Dec; 12():1335-54. PubMed ID: 14096421
    [No Abstract]   [Full Text] [Related]  

  • 16. ANTITUMOR ACTIVITY OF GOSSYPOL IN EXPERIMENTS ON TRANSPLANTABLE TUMORS.
    VERMEL EM; KRUGLYAK SA
    Fed Proc Transl Suppl; 1965; 24():106-8. PubMed ID: 14275562
    [No Abstract]   [Full Text] [Related]  

  • 17. [EXPERIMENTAL ANTICANCER STUDIES. 23. FURTHER EXPERIMENTS ON THE ANTITUMOR ACTIVITY OF 4-AMINO-6-OCTYLRESORCINOL HYDROCHLORIDE].
    KOSHIURA R; KOSHIMURA S; BANDO Y
    Gan; 1964 Oct; 55():433-41. PubMed ID: 14247592
    [No Abstract]   [Full Text] [Related]  

  • 18. Histochemical study on enzymes of cancer cells in ascites.
    TAKEUCHI T; MAEDA A; TSUTSUMI I
    Gan; 1955 Sep; 46(2-3):209-10. PubMed ID: 13262328
    [No Abstract]   [Full Text] [Related]  

  • 19. CROSS RESISTANCE AND COLLATERAL SENSITIVITY STUDIES IN CANCER CHEMOTHERAPY.
    HUTCHISON DJ
    Adv Cancer Res; 1963; 7():235-50. PubMed ID: 14153767
    [No Abstract]   [Full Text] [Related]  

  • 20. MECHANISMS OF RESISTANCE TO ANTICANCER AGENTS.
    BROCKMAN RW
    Adv Cancer Res; 1963; 7():129-234. PubMed ID: 14153765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.